Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN -null glioblastoma
Xiangrong Ni, Wei-Chi Wu, Xiaoqiang Sun, et al.
Science Advances (2022) Vol. 8, Iss. 27
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 200
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
Beyond T cell exhaustion: TIM-3 regulation of myeloid cells
Karen O. Dixon, Gonzalo Fernandez Lahore, Vijay K. Kuchroo
Science Immunology (2024) Vol. 9, Iss. 93
Closed Access | Times Cited: 18
Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma
Haibin Wu, Chengcheng Guo, Chaoye Wang, et al.
Cancer Science (2023) Vol. 114, Iss. 6, pp. 2609-2621
Open Access | Times Cited: 26
Tumor-associated macrophage-related strategies for glioma immunotherapy
Fansong Tang, Yuelong Wang, Yunhui Zeng, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 26
Myeloid cells as potential targets for immunotherapy in pediatric gliomas
Stephen C. Frederico, Nikhil Sharma, Corbin Darling, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 7
IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy
Feng Ye, Lichong Wang, Yuanyou Li, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Macrophage plasticity and function in cancer and pregnancy
Tingxuan Yin, Xinyi Li, Yanhong Li, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Role of the AKT signaling pathway in regulating tumor-associated macrophage polarization and in the tumor microenvironment: A review
Cong Liang, Song Wang, Chengwei Wu, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41379-e41379
Open Access
Sphingosine kinase 1 promotes M2 macrophage infiltration and enhances glioma cell migration via the JAK2/STAT3 pathway
Zihan Song, Zijun Zhao, Xuehua Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Circadian rhythm related genes signature in glioma for drug resistance prediction: a comprehensive analysis integrating transcriptomics and machine learning
Junbo Liao, Yingxing Duan, Xiangwang Xu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Sophocarpine inhibits the proliferation and induces apoptosis of glioblastoma cells through regulating the miR-21/PTEN/PI3K/AKT axis
Si Feng, Qian Wang, Fei Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Tumor-associated monocytes promote mesenchymal transformation through EGFR signaling in glioma
Yiyun Chen, Ran Huo, Weirong Kang, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 9, pp. 101177-101177
Open Access | Times Cited: 16
The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets
Jiangbin Ren, Bangjie Xu, Jianghao Ren, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1269-1269
Open Access | Times Cited: 14
An NFAT1-C3a-C3aR Positive Feedback Loop in Tumor-Associated Macrophages Promotes a Glioma Stem Cell Malignant Phenotype
Yaochuan Zhang, Yifu Song, Xiaoliang Wang, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 3, pp. 363-376
Open Access | Times Cited: 5
Diffuse large B-cell lymphoma: the significance of CD8+ tumor-infiltrating lymphocytes exhaustion mediated by TIM3/Galectin-9 pathway
Qiqi Zhu, Yiming Yang, Kexin Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
The multiple roles of interferon regulatory factor family in health and disease
Lianzhou Wang, Yanghui Zhu, Nan Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Galectin functions in cancer-associated inflammation and thrombosis
Linus Kruk, Attila Braun, Érika Cosset, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Investigating the effects of PTEN mutations on cGAS-STING pathway in glioblastoma tumours
Eda Doğan, Zafer Yildirim, Taner Akalın, et al.
Journal of Neuro-Oncology (2024) Vol. 166, Iss. 2, pp. 283-292
Open Access | Times Cited: 3
GRP/GRPR enhances alcohol-associated liver injury through the IRF1-mediated Caspase-1 inflammasome and NOX2-dependent ROS pathway
Hai-Di Li, Xin Chen, Jiejie Xu, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 392-408
Closed Access | Times Cited: 11
Do galectins serve as soluble ligands for immune checkpoint receptors?
Nicolás I. Torres, Federico G. Baudou, Marco A Scheidegger, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e008984-e008984
Open Access | Times Cited: 3
Implantable Microneedle‐Mediated Eradication of Postoperative Tumor Foci Mitigates Glioblastoma Relapse
Yulin Zhang, Z Fang, Zejuan Liu, et al.
Advanced Materials (2024)
Open Access | Times Cited: 3
Microglia–T cell conversations in brain cancer progression
Reza Mirzaei, V. Wee Yong
Trends in Molecular Medicine (2022) Vol. 28, Iss. 11, pp. 951-963
Closed Access | Times Cited: 17
Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy
Zhao‐Ru Dong, Jia‐Bin Cai, Guo‐Ming Shi, et al.
Cancer Letters (2023) Vol. 564, pp. 216186-216186
Closed Access | Times Cited: 8
Early‐Responsive Immunoregulation Therapy Improved Microenvironment for Bone Regeneration Via Engineered Extracellular Vesicles
Tingwei Lu, Yuanqi Liu, Xiangru Huang, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 11
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top